Sustained Attention and Interference Control Among 7-Year-Old Children With a Familial High Risk of Schizophrenia or Bipolar Disorder-A Nationwide Observational Cohort Study
Overview
Authors
Affiliations
Background: Given the partially shared genetic liability between schizophrenia and bipolar disorder, we aimed to assess whether 7-year-old children with a familial high risk of schizophrenia or bipolar disorder display specific deficits of sustained attention and interference control compared with each other and with control children.
Methods: An observational cohort was identified through Danish registries and consisted of 522 children 7 years of age with no, one, or two parents with a diagnosis of schizophrenia or bipolar disorder. Control subjects were matched based on age, sex, and municipality. Sustained attention and interference control were assessed using Conners' Continuous Performance Test II and a modified Eriksen flanker task. Assessors were blinded to group membership of participants. The effect of higher genetic loading was not considered in the statistical models owing to low numbers.
Results: At 7 years of age, children with a familial high risk of schizophrenia displayed deficits of sustained attention and subtle deficits in interference control compared with control children and children with a familial high risk of bipolar disorder. Children with a familial high risk of bipolar disorder displayed similar abilities of sustained attention and interference control as control children except in terms of a lower accuracy.
Conclusions: Our findings suggest distinct neurodevelopmental characteristics in middle childhood of sustained attention and interference control for children of parents with schizophrenia or bipolar disorder.
MESS to live with schizophrenic parental history: A systematic review of developmental checkpoints.
Khan M, Batool R, Mushtaq U, Iqbal S, Shaheen S, Butt A PLoS One. 2025; 20(1):e0313531.
PMID: 39813242 PMC: 11734903. DOI: 10.1371/journal.pone.0313531.
Yu S, Hwang T, Liu C, Chan H, Kuo C, Yang T BMC Psychiatry. 2024; 24(1):155.
PMID: 38389072 PMC: 10885443. DOI: 10.1186/s12888-024-05598-2.
Johnsen L, Larsen K, Fuglsang S, Ver Loren van Themaat A, Christiaan Baare W, Madsen K Schizophr Bull. 2023; 50(3):567-578.
PMID: 37756493 PMC: 11059809. DOI: 10.1093/schbul/sbad134.
Cattarinussi G, Gugliotta A, Sambataro F Int J Environ Res Public Health. 2023; 20(15).
PMID: 37569080 PMC: 10418911. DOI: 10.3390/ijerph20156540.
Knudsen C, Hemager N, Jepsen J, Gregersen M, Greve A, Andreassen A Schizophr Bull. 2022; 49(3):756-767.
PMID: 36548470 PMC: 10154705. DOI: 10.1093/schbul/sbac198.